OICR News / Tag

Laszlo Radvanyi

TAG ARCHIVE

Browse news tagged Laszlo Radvanyi.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

Talent

Ask a Cancer Researcher: How does a tumour’s genetics factor into cancer care?

Dr. Laszlo Radvanyi, OICR’s President and Scientific Director, answers a question about precision medicine and discusses how OICR is working to improve access to this form of cancer treatment through the development of liquid biopsies.…

ArticleJul 05, 2024

TalentTreatment

Ask a Cancer Researcher: What is immunotherapy?

OICR’s President and Scientific Director Dr. Laszlo Radvanyi answers a question from the public. In our latest Ask a Cancer Researcher video, we cover one of the most talked about types of cancer treatment. OICR…

ArticleJun 21, 2023

Technology

Standards redefined: What lab accreditation means to OICR Genomics

OICR Genomics believes high-quality cancer research starts with high-quality data. Since inception, their labs have been committed to quality, and now accreditation is within reach Standards are all around us – making our lives safer…

ArticleFeb 03, 2021

Collaboration

Imagining the next 20 years and planning for the next five

How OICR is using strategic foresight to prepare for the future and inform its 2021-2026 Strategic Plan OICR focuses on translating cancer research discoveries and transforming cancer care. Achieving this mission, however, is dependent on…

ArticleFeb 03, 2021

Collaboration

What we learned at the recent OICR-JLABS cell therapy symposium

OICR and Johnson & Johnson Innovation – JLABS @ Toronto launch the OICR-JLABS Cancer Symposium Series, featuring leaders, innovators and trail blazers in cell therapy On January 28, OICR and JLABS @ Toronto hosted the…

ArticleFeb 03, 2021

Collaboration

A message from OICR’s President and Scientific Director, Dr. Laszlo Radvanyi

I hope that everyone has continued to stay safe and healthy as the world continues to grapple with the risks and challenges presented by COVID-19. The impacts of the pandemic have been felt by individuals…

ArticleMay 06, 2020

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Laszlo Radvanyi

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Ask a Cancer Researcher: How does a tumour’s genetics factor into cancer care?

Ask a Cancer Researcher: What is immunotherapy?

Standards redefined: What lab accreditation means to OICR Genomics

Cancer solved together — in your inbox

Imagining the next 20 years and planning for the next five

What we learned at the recent OICR-JLABS cell therapy symposium

A message from OICR’s President and Scientific Director, Dr. Laszlo Radvanyi